MolMed S.p.A. (MLM) - Financial and Strategic Analysis ReviewMolMed S.p.A. (Molmed) is a biotechnology company, engaged in the research, development and clinical validation of new therapies for the treatment of cancer. Its product pipeline includes NGR-hTNF, NGR-IFNg and NGR-IL12. Its lead drug candidate, NGR-hTNF is undergoing Phase III clinical development both as monotherapy and in combination therapy, in a total of six indications. It has...more
Sinovac Biotech Ltd. (SVA) - Financial and Strategic Analysis ReviewSinovac Biotech Ltd. engages in the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases including hepatitis A, seasonal influenza, H5N1 (bird flu) pandemic influenza and H1N1 influenza. Sinovac was the first company worldwide to receive approval for H1N1 influenza vaccine. In November 2009, the company formed joint...more
Velcera, Inc. (VLCR) - Financial and Strategic Analysis ReviewVelcera, Inc. (Velcera) is a is a development stage specialty pharmaceutical company, engaged in the acquisition, development and commercialization of pharmaceutical products for the pet health market. Velcera is focused on developing pet medicines in pain management, anti-allergy and parasiticides. Velcera's patented Promist drug delivery technology provides various advantages when compared to conventional swallow tablets and liquids. Promist drug delivery technology provides a metered dose liquid mist to the inside of the mouth for systemic absorption of the drug. The company is headquartered at Yardley in Pennsylvania, the USThis comprehensive SWOT profile of Velcera, Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.This company report forms part of the Profile on...more
Viral Genetics, Inc. (VRAL) - Financial and Strategic Analysis ReviewViral Genetics, Inc. (Viral Genetics) is a biotechnology company, engaged in the discovery, development and commercialization of immune based therapies using its thymus nuclear protein compound for the treatment of serious diseases and autoimmune conditions. Viral Genetics is...more
Cordex Pharma, Inc. (CDXP) - Financial and Strategic Analysis ReviewCordex Pharma, Inc. (Cordex Pharma) is a pharmaceutical company that develops therapeutic and diagnostic products. It also develops cardiovascular medicines that are based upon the pharmacology of adenosine 5-triphosphate (ATP) and nitric oxide (NO). Its products include ATPace is...more
Myriad Pharmaceuticals, Inc. (MYRX) - Financial and Strategic Analysis ReviewMyriad Pharmaceuticals, Inc. (Myriad Pharmaceuticals) is a pharmaceutical company, engaged in the discovery, development, and commercialization of small molecule drug candidates for the medical conditions of cancer and HIV. Its clinical stage pipeline products include Azixa (MPC-6827), MPC-3100, MPC-4326. Azixa is an investigational drug candidate being developed in Phase II clinical trials for the treatment of patients with GBM and advanced primary and metastatic tumors. MPC-3100 is in Phase I clinical study for the treatment of Cancer and MPC-4326 is in Phase II study for HIV.Myriad Pharmaceuticals, Inc. Key Recent DevelopmentsFeb 16, 2010: Myriad Pharmaceuticals Q2 2009 Net Loss Narrows DownDec 01, 2009: Myriad Starts Phase IIb Study Of HIV DrugNov 12, 2009: Myriad Reports Net Loss Of $10.6 Million For Q1 Fiscal 2010Oct 13, 2009: Myriad Identifies IND Candidate For Treatment Of Cancer, Obesity, DiabetesThis comprehensive SWOT profile of Myriad Pharmaceuticals, Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear...more
Earlier, buying a Digital Video Disc player meant causing a deep hole in your purse. Not so anymore, as today they are available at a fraction of their earlier amount. As a matter of fact, Wholesale DVDs are now available for a minimum of $25, which...more
Genexine Co., Ltd. (95700) - Financial and Strategic Analysis ReviewGenexine Co., Ltd. (Genexine) is involved in the research and development of therapeutic vaccines for incurable diseases and next-generation antibody fusion protein drugs such as...more
Propharex (PROP) - Financial and Strategic Analysis ReviewPropharex is a specialty pharmaceutical company specialized in the conception, the construction, the delivery and the assembly of "turnkey" modular pharmaceutical plants. The company supplies...more
Zhongtian International Limited (2379) - Financial and Strategic Analysis ReviewZhongtian International Limited (Zhongtian International) is an investment holding company engaged in trading of software and hardware products. The company also offers...more
Giaconda Limited (GIA) - Financial and Strategic Analysis ReviewGiaconda Limited (Giaconda) is a research focused biotechnology company, engaged in research, development and commercialization of innovative therapeutics for gastrointestinal diseases...more
CytoDyn, Inc. (CYDY) - Financial and Strategic Analysis ReviewCytoDyn, Inc. (CytoDyn) is a biotechnology research company that is engaged in the development of drugs to treat HIV/AIDS. The company is a member of New Mexico Biotechnology and...more